Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-18-014093
Filing Date
2018-03-12
Accepted
2018-03-12 16:00:46
Documents
5
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tv488316_10k-a.htm 10-K/A 103567
2 EXHIBIT 31.1 tv488316_ex31-1.htm EX-31.1 11220
3 EXHIBIT 31.2 tv488316_ex31-2.htm EX-31.2 11298
4 EXHIBIT 32.1 tv488316_ex32-1.htm EX-32.1 3356
5 EXHIBIT 32.2 tv488316_ex32-2.htm EX-32.2 3463
  Complete submission text file 0001144204-18-014093.txt   133994
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36357 | Film No.: 18683340
SIC: 2834 Pharmaceutical Preparations